Harshbarger Benjamin 4
4 · CATABASIS PHARMACEUTICALS INC · Filed Jun 12, 2020
Insider Transaction Report
Form 4
Harshbarger Benjamin
Chief Legal Officer
Transactions
- Award
Stock Option (right to buy)
2020-06-11+45,000→ 45,000 totalExercise: $6.17Exp: 2030-06-10→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]This option was granted on June 11, 2020 and is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of June 8, 2020 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.